• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中的自然杀伤细胞可塑性

NK Cell Plasticity in Cancer.

作者信息

Liu Sizhe, Dhar Payal, Wu Jennifer D

机构信息

Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

Robert Lurie Comprehensive Cancer Center, Chicago, IL 60611, USA.

出版信息

J Clin Med. 2019 Sep 19;8(9):1492. doi: 10.3390/jcm8091492.

DOI:10.3390/jcm8091492
PMID:31546818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6780970/
Abstract

Natural killer (NK) cells are critical immune components in controlling tumor growth and dissemination. Given their innate capacity to eliminate tumor cells without prior sensitization, NK-based therapies for cancer are actively pursued pre-clinically and clinically. However, recent data suggest that tumors could induce functional alterations in NK cells, polarizing them to tumor-promoting phenotypes. The potential functional plasticity of NK cells in the context of tumors could lead to undesirable outcomes of NK-cell based therapies. In this review, we will summarize to-date evidence of tumor-associated NK cell plasticity and provide our insights for future investigations and therapy development.

摘要

自然杀伤(NK)细胞是控制肿瘤生长和扩散的关键免疫成分。鉴于其无需预先致敏就能消除肿瘤细胞的固有能力,基于NK细胞的癌症疗法正在临床前和临床阶段积极开展研究。然而,最近的数据表明肿瘤可能会诱导NK细胞发生功能改变,使其极化成为促进肿瘤的表型。在肿瘤环境中,NK细胞潜在的功能可塑性可能导致基于NK细胞的疗法产生不良后果。在这篇综述中,我们将总结迄今为止关于肿瘤相关NK细胞可塑性的证据,并为未来的研究和治疗发展提供我们的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efbd/6780970/9c6b77c37e62/jcm-08-01492-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efbd/6780970/9c6b77c37e62/jcm-08-01492-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efbd/6780970/9c6b77c37e62/jcm-08-01492-g001.jpg

相似文献

1
NK Cell Plasticity in Cancer.癌症中的自然杀伤细胞可塑性
J Clin Med. 2019 Sep 19;8(9):1492. doi: 10.3390/jcm8091492.
2
Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics.解决基于细胞的癌症治疗中自然杀伤细胞功能障碍和可塑性问题。
Cancers (Basel). 2023 Mar 13;15(6):1743. doi: 10.3390/cancers15061743.
3
Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors.增强自然杀伤(NK)细胞对实体瘤活性的策略。
Cancers (Basel). 2019 Jul 23;11(7):1040. doi: 10.3390/cancers11071040.
4
Role of Distinct Natural Killer Cell Subsets in Anticancer Response.不同自然杀伤细胞亚群在抗癌反应中的作用。
Front Immunol. 2017 Mar 16;8:293. doi: 10.3389/fimmu.2017.00293. eCollection 2017.
5
Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity.基于自然杀伤细胞的癌症治疗:获得并维持抗肿瘤活性的可能策略。
Front Immunol. 2015 Nov 30;6:605. doi: 10.3389/fimmu.2015.00605. eCollection 2015.
6
Natural killer cells and solid tumors.自然杀伤细胞与实体瘤。
J Innate Immun. 2011;3(4):355-64. doi: 10.1159/000325465. Epub 2011 Apr 18.
7
What Defines NK Cell Functional Fate: Phenotype or Metabolism?NK 细胞功能命运由何决定:表型还是代谢?
Front Immunol. 2019 Jun 19;10:1414. doi: 10.3389/fimmu.2019.01414. eCollection 2019.
8
Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy.犬自然杀伤细胞在癌症免疫治疗中的特性及潜在应用
J Clin Med. 2019 Oct 27;8(11):1802. doi: 10.3390/jcm8111802.
9
The breast tumor microenvironment alters the phenotype and function of natural killer cells.乳腺肿瘤微环境会改变自然杀伤细胞的表型和功能。
Cell Mol Immunol. 2016 Sep;13(5):628-39. doi: 10.1038/cmi.2015.42. Epub 2015 Aug 17.
10
Pharmacological targeting of natural killer cells for cancer immunotherapy.自然杀伤细胞的药理学靶向在癌症免疫治疗中的应用。
Cancer Sci. 2020 Jun;111(6):1869-1875. doi: 10.1111/cas.14418. Epub 2020 May 5.

引用本文的文献

1
EPHB1 Protein Promoted the Progression of Prostate Adenocarcinoma Through Phosphorylating GSK3B and Activating EPHB1-GSK3B-SMAD3 Pathway.EPHB1蛋白通过磷酸化GSK3B和激活EPHB1-GSK3B-SMAD3信号通路促进前列腺腺癌进展。
Hum Mutat. 2025 Jun 12;2025:4961883. doi: 10.1155/humu/4961883. eCollection 2025.
2
The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives.肿瘤微环境在胰腺癌免疫治疗中的作用:现状与未来展望。
Int J Mol Sci. 2024 Sep 3;25(17):9555. doi: 10.3390/ijms25179555.
3
No time to die: Epigenetic regulation of natural killer cell survival.

本文引用的文献

1
Therapeutic blockade of activin-A improves NK cell function and antitumor immunity.治疗性阻断激活素 A 可改善 NK 细胞功能和抗肿瘤免疫。
Sci Signal. 2019 Aug 27;12(596):eaat7527. doi: 10.1126/scisignal.aat7527.
2
Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function.子宫内膜肿瘤微环境改变人自然杀伤细胞的募集,以及驻留自然杀伤细胞的表型和功能。
Front Immunol. 2019 Apr 26;10:877. doi: 10.3389/fimmu.2019.00877. eCollection 2019.
3
A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients.
无暇赴死:自然杀伤细胞存活的表观遗传调控。
Immunol Rev. 2024 May;323(1):61-79. doi: 10.1111/imr.13314. Epub 2024 Mar 1.
4
Global research trends on innate lymphoid cells in the brain, gut and lung field: a bibliometric and visualized analysis.全球脑、肠和肺领域固有淋巴细胞研究趋势:文献计量学和可视化分析。
Front Immunol. 2024 Feb 7;15:1336666. doi: 10.3389/fimmu.2024.1336666. eCollection 2024.
5
Immunotherapy and Pancreatic Cancer: A Lost Challenge?免疫疗法与胰腺癌:一项难以攻克的挑战?
Life (Basel). 2023 Jun 30;13(7):1482. doi: 10.3390/life13071482.
6
Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy.靶向三阴性乳腺癌中的 TRAIL 死亡受体:癌症治疗的挑战与策略。
Cells. 2022 Nov 22;11(23):3717. doi: 10.3390/cells11233717.
7
NK cells with decreased expression of multiple activating receptors is a dominant phenotype in pediatric patients with acute lymphoblastic leukemia.多种激活受体表达降低的自然杀伤细胞是急性淋巴细胞白血病儿科患者的主要表型。
Front Oncol. 2022 Nov 7;12:1023510. doi: 10.3389/fonc.2022.1023510. eCollection 2022.
8
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes.胰腺癌的免疫疗法:我们为何屡战屡败?聚焦肿瘤免疫微环境、预测性生物标志物与治疗结果
Cancers (Basel). 2022 May 14;14(10):2429. doi: 10.3390/cancers14102429.
9
Plasticity of NK cells in Cancer.NK 细胞在癌症中的可塑性。
Front Immunol. 2022 May 10;13:888313. doi: 10.3389/fimmu.2022.888313. eCollection 2022.
10
Current Limitations and Novel Perspectives in Pancreatic Cancer Treatment.胰腺癌治疗的当前局限与新视角
Cancers (Basel). 2022 Feb 16;14(4):985. doi: 10.3390/cancers14040985.
一个预测黑色素瘤患者自然杀伤细胞浸润和改善生存的基因特征。
Cancer Immunol Res. 2019 Jul;7(7):1162-1174. doi: 10.1158/2326-6066.CIR-18-0500. Epub 2019 May 14.
4
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia.异基因自然杀伤细胞过继转移用于儿科急性髓系白血病巩固治疗的 II 期临床试验。
J Immunother Cancer. 2019 Mar 20;7(1):81. doi: 10.1186/s40425-019-0564-6.
5
The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy.自然杀伤细胞在癌症免疫治疗中的重要作用
Trends Immunol. 2019 Feb;40(2):142-158. doi: 10.1016/j.it.2018.12.003. Epub 2019 Jan 10.
6
Natural Killer Cell-Based Cancer Immunotherapy: A Review on 10 Years Completed Clinical Trials.基于自然杀伤细胞的癌症免疫疗法:对已完成的10年临床试验的综述
Cancer Invest. 2018;36(8):431-457. doi: 10.1080/07357907.2018.1515315. Epub 2018 Oct 16.
7
Lack of FcRn Impairs Natural Killer Cell Development and Functions in the Tumor Microenvironment.缺乏 FcRn 会损害肿瘤微环境中的自然杀伤细胞发育和功能。
Front Immunol. 2018 Sep 28;9:2259. doi: 10.3389/fimmu.2018.02259. eCollection 2018.
8
Innate Lymphoid Cells: 10 Years On.先天淋巴细胞:十年进展。
Cell. 2018 Aug 23;174(5):1054-1066. doi: 10.1016/j.cell.2018.07.017.
9
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity.人诱导多能干细胞来源的嵌合抗原受体修饰自然杀伤细胞增强抗肿瘤活性。
Cell Stem Cell. 2018 Aug 2;23(2):181-192.e5. doi: 10.1016/j.stem.2018.06.002. Epub 2018 Jun 28.
10
Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression.肺癌进展过程中 FBP1 诱导的糖酵解抑制导致自然杀伤细胞功能障碍。
Cell Metab. 2018 Aug 7;28(2):243-255.e5. doi: 10.1016/j.cmet.2018.06.021. Epub 2018 Jul 19.